3417.T
Latest Trade
1,004.00JPYChange
-6.00(-0.59%)Volume
100Today's Range
-
1,004.0052 Week Range
-
1,510.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 1,010.00 |
|---|---|
Open | 1,004.00 |
Volume | 100 |
3M AVG Volume | 0.07 |
Today's High | 1,004.00 |
Today's Low | 1,004.00 |
52 Week High | 1,510.00 |
52 Week Low | 699.00 |
Shares Out (MIL) | 13.83 |
Market Cap (MIL) | 14,128.39 |
Forward P/E | -- |
Dividend (Yield %) | 1.79 |
Ohki Healthcare Holdings names Hidemasa Matsui as president
Ohki Healthcare Holdings to repurchase shares
Ohki Healthcare Holdings announces merger between wholly owned subsidiary and wholly owned sub-subsidiary
Ohki Healthcare Holdings Co., Ltd. is a Japan-based company mainly engaged in the management of its subsidiaries. The Company operates the production and sales of pharmaceutical products segment. The Company provides various products, such as pharmaceutical products, health food, Health care products, nursing care products, oral products, baby products, daily necessities and clothing, confectionery, food, cosmetics and others.
Industry
Biotechnology & Drugs
Executive Leadership
Hideo Matsui
Chairman of the Board, President, Representative Director
Hidemasa Matsui
Vice President, Manager of Business Planning, Representative Director
Motoaki Hirano
Senior Managing Director, Chief Director of International Business in Sales Supervisor Unit, President of Osaka Office, Representative Director
Yoshinobu Ube
Senior Managing Director, Chief Director of Sales Planning, Representative Director
Masaaki Ueki
Managing Director, Chief Director of Sales
Price To Earnings (TTM) | 6.65 |
|---|---|
Price To Sales (TTM) | 0.05 |
Price To Book (MRQ) | 0.78 |
Price To Cash Flow (TTM) | 5.58 |
Total Debt To Equity (MRQ) | 40.16 |
LT Debt To Equity (MRQ) | 2.80 |
Return on Investment (TTM) | 10.23 |
Return on Equity (TTM) | 2.09 |
* Says it names current vice president Hidemasa Matsui as president, effective June 29
* Says it plans to repurchase up to 1 million shares of its common stock, representing 7.1 percent of outstanding, during period from Oct. 10 to March 31, 2018
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.